Biocard C.pneumoniae IgM

Biocard C.pneumoniae IgM Specification

Technology
Modern

Color
Multicolor

Function
Hospital Use

Application
For Hospital amd Clinic Purpose

Condition
New

Portable
Yes

Use
Medical Use

Biocard C.pneumoniae IgM Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
1 Piece Per Week

Delivery Time
1-6 Week

Main Export Market(s)
Australia, North America, Eastern Europe, Middle East, Western Europe, Africa, Central America, South America, Asia

Main Domestic Market
All India

About Biocard C.pneumoniae IgM

overview

Biocard C. pneumoniae IgM test is a rapid immunochromatographic lateral flow test that detects IgM antibodies against Chlamydophila pneumoniae (Chlamydia pneumoniae ) from a blood or serum sample. The test also contains an integrated control system
All the accessories needed for the sampling and testing are included
Only drop of blood or serum needed
The test can be performed and evaluated in 10 minutes
Biocard is a trademark listed in the Master lists of the College of American Pathologists (CAP) Proficiency testing
(PT).

Benefits

Unique as can be run on fingertip blood samples, no need for intravenous sampling and separating the serum
Results can be obtained in 10 minutes, e.g during a doctors appointment
Can be stored at room temperature meaning no need for cold storage and kits are always ready-to-use
Easy procedure with very little hands-on time
Flexibility on sample material also intravenous whole blood and serum can be used.

Technical Specifications

Biocard C.pneumoniae IgM, 10 tests Cat. 3-034-000

Advanced Diagnostic Technology

Leveraging modern diagnostic techniques, Biocard C.pneumoniae IgM offers healthcare providers reliable detection of C.pneumoniae IgM antibodies. This facilitates early diagnosis, supporting timely and effective patient management, crucial in hospital and clinic environments.

Portable and User-Friendly Design

The tests portable format and vibrant multicolor presentation make it easy to use and interpret, even in hectic medical settings. Its design supports rapid deployment in hospitals or clinics, enhancing workflow and improving patient care outcomes.

FAQs of Biocard C.pneumoniae IgM:

Q: How is the Biocard C.pneumoniae IgM test used in a hospital or clinic setting?

A: The Biocard C.pneumoniae IgM test is used by healthcare professionals to detect the presence of specific IgM antibodies linked to Chlamydophila pneumoniae infections. Its portable design allows for quick testing and rapid result interpretation within hospitals and clinics.

Q: What technology does this diagnostic tool utilize?

A: This test employs advanced immunochromatographic technology, ensuring modern, fast, and accurate detection of C.pneumoniae IgM by using a multicolor readout for straightforward results.

Q: When should this test be administered?

A: The Biocard C.pneumoniae IgM test is recommended when patients present symptoms or clinical suspicion of C.pneumoniae infection. Early use enables timely intervention and better patient outcomes.

Q: Where is Biocard C.pneumoniae IgM manufactured and available?

A: Manufactured in India, this diagnostic product is distributed, exported, and supplied to hospitals and clinics across various regions, making it widely accessible for medical professionals.

Q: What is the process for performing the C.pneumoniae IgM test?

A: A blood sample is collected and applied to the test device according to the included instructions. The simple workflow enables rapid processing, delivering results in just a short time.

Q: How does this test benefit hospitals and clinics?

A: With its quick setup, modern technology, and portable design, the Biocard C.pneumoniae IgM test allows hospitals and clinics to diagnose infections efficiently, improving patient management and reducing waiting times.